![Kyle Jenne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Kyle Jenne is currently Chief Global Product Strategy Officer & EVP at Ionis Pharmaceuticals, Inc. since 2024.
Former roles include Chief Executive Officer & Director at Elsie Biotechnologies Inc., Chief Commercial Officer & Executive VP at Ionis Pharmaceuticals, Inc., and Senior Vice President-US Commercial at Akcea Therapeutics, Inc. from 2017 to 2019.
Education includes undergraduate studies at Arizona State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/04/2026 | 23.713 ( 0,01 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/02/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Director Ejecutivo | - |
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
